Wall Street is Behind the Curve on Foreign Exchange Impact
Insights - Across the market, multinational companies are blaming missed earnings and lower-than-expected 2015 guidance on foreign exchange effects and cheap oil.
Read nowAuthor Archives: Editorial Staff
The Highest Biotech Fliers Last Week were the Hardest Hit this Week
The Biggest Investor Event in Healthcare Starts Next Week
Recap - Investors descend en masse on San Francisco next week for the annual JP Morgan healthcare conference, a major event for the sector that historically generates … Continue Reading
Read now2014 was Stellar for Biotech. Here’s to an Even Better 2015
Insights - 2014 was a stellar year in biotech, for investors as well as patients. Here’s to an even better 2015. Happy new year! At PropThink, our goal has always … Continue Reading
Read nowOne and One from Last Week’s Recap
Recap - Merry Christmas and Happy Holidays! Wishing you and yours a spectacular 2015! We were one and one in last week’s healthcare recap. The v-bottom played out as many expected, … Continue Reading
Read now
HCV Going Through Growing Pains as Achillion Data Hits
Research - Achillion Pharmaceuticals (ACHN) reported anticipated data for its nucleotide inhibitor ACH-3422 this morning alongside data from a phase 2 proxy study.
PremiumV-Bottom’s Back, Gilead’s Biggest Overhang is Removed: Our Weekly Recap
Recap - We’re in the throes of yet another sharp “V-bottom” for the S&P 500 (SPX), a rapid drop followed by a rip-your-face off rally – the 10th occurrence … Continue Reading
Read now